Mrs. Vicki Lynn Joseph, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 216 Riviera Dr, Rio Vista, CA 94571 Phone: 707-448-6841 |
News Archive
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
The study of muscular system protein myostatin has been of great interest to researchers as a potential therapeutic target for people with muscular disorders. Although much is known about how myostatin affects muscle growth, there has been disagreement about what types of muscle cells it acts upon. New research from a team including Carnegie's Chen-Ming Fan and Christoph Lepper narrows down the field to one likely type of cell.
APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.
Men lead women in the likelihood to die from nearly all the most common causes of death. Still, men are less likely to go to the doctor than women and often try to ignore symptoms of health problems.
In GlobalPost's "Global Pulse" blog, Mia Mazer, a media and communications intern with the International Planned Parenthood Federation/Western Hemisphere Region, writes about the formation of the Mesoamerican Coalition for Comprehensive Sexuality Education, a regional advocacy initiative of more than 40 different organizations that aims to hold governments accountable to a 2008 Ministerial Declaration, titled "Preventing through Education."
› Verified 8 days ago